Unhealed Duodenal Ulcers despite Helicobacter pylori Eradication

References

• N1H Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994; 272: 65–9
   PubMed Web of Science ®Google Scholar
• Marshall B J, Warren J B, Blincow E D, Phillips M, Goodwin C S, Murray R, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–42
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Evans D G, Evans DJ, Jr, Klein PK. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing with ranitidine. Ann Intern Med 1991; 115: 266–9
   PubMed Web of Science ®Google Scholar
• Hosking S W, Ling TKW, Yung MY. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502–4
   PubMed Web of Science ®Google Scholar
• Hentschell E, Brandstatter G, Dragosics B. Effect of ranitidine and amoxycilline plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308–12
   PubMed Web of Science ®Google Scholar
• McCarthy C J, Colins R, Beattie S, Hamilton H, O'Morain C. Short report: treatment of Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502–4
   PubMedGoogle Scholar
• O'Connor H J, Kanduru C, Bhutta A S, Meehan J M, Feeley K M, Cunnane K. Effect of Helicobacter pylori eradication on peptic ulcer healing. Postgrad Med J 1995; 71: 90–3
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Boixeda D, Redondo C, Alvarez Baleriola I, Jimenez I, et al. Breath test for the diagnosis of Helicobacter pylori infection: concordance with histologic methods and correlation with histologic lesions of the gastric mucosa. Rev Esp Enferm Dig 1996; 88: 259–64
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Boixeda D, Vila T, De Rafael L, Redondo C, Martin De Argila C. Basal and stimulated gastrin levels and gastric acid output five months after therapy for Helicobacter pylori eradication in duodenal ulcer patients. J Clin Gastroenterol 1996; 22: 90–5
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Boixeda D, Vila T, De Rafael L, Redondo C, Canton R, et al. Verification of decreased basal and stimulated serum pepsinogen I levels is a useful non-invasive method for determining the success of eradication therapy of Helicobacter pylori. Scand. J Gastroenterol 1996; 31: 103–10
   Web of Science ®Google Scholar
• Brady CHE. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome. Am J Gastroenterol 1991; 86: 129–34
   PubMed Web of Science ®Google Scholar
• Lam S K, Lee N W, Koo J, Hui W M, Fok K H, Ng M. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine. Gut 1984; 25: 703–6
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G, Parente F, Lazzaroni M. Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers. Gut 1987; 28: 907–11
   PubMed Web of Science ®Google Scholar
• Bazzoli F, Zagari R M, Fossi S, Pozzato P, Alampi G, Simoni P, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur. J Gastroenterol 1994; 6: 773–7
   Web of Science ®Google Scholar
• Lind T, Veldhuyzen SJO, Unge P, Spiller R C, Bayerdorffer E, O'Morain C, et al. The MACH 1 study: optimal one-week treatment for Helicobacter pylori defined? [abstract]. Gut 1995; 37: A186, Suppl 2
   Google Scholar
• Gisbert J P, Boixeda D, Mur Villacampa M, Mones J, Sainz Samitier R, Martin De Argila C. Response to article by Dr. Forne et al. Am J Gastroenterol 1996; 91: 176–7
   PubMedGoogle Scholar
• Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–6
   PubMed Web of Science ®Google Scholar
• Bianchi Porro G, Parente F, Lazzaroni M. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralphate alone. Gut 1993; 34: 466–9
   PubMed Web of Science ®Google Scholar
• Mantzaris G J, Athanassios H, Tamvkologos G. Prospective, randomized, investigator-blind trial of Helicobacter pylori infection treatment in patients with refractory duodenal ulcers. Healing and long-term relapse rates. Dig Dis Sci 1993; 38: 1132–5
   PubMed Web of Science ®Google Scholar
• Lanas A, Remacha B, Esteva F, Sainz R. Risk factors associated with refractory peptic ulcers. Gastroenterology 1995; 109: 1124–33
   PubMed Web of Science ®Google Scholar
• El-Omar E, Penman I D, Ardill JES, Chittajallu R S, Howie C, McColl KEL. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681–91
   PubMed Web of Science ®Google Scholar
• Hogan D L, Rapier R C, Dreilinger A, Koss M A, Basuk P M, Weinstein W M, et al. Duodenal bicarbonate secretion: eradication of Helicobacter pylori and duodenal structure and function in humans. Gastroenterology 1996; 110: 705–16
   PubMed Web of Science ®Google Scholar
• Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–25
   PubMed Web of Science ®Google Scholar
• Goodwin C S. Duodenal ulcer, Campylobacter pylori, and the 'leaking roof concept. Lancet 1988; 2: 1467–8
   PubMed Web of Science ®Google Scholar
• Walt R P, Daneshmend T K. Resistant duodenal ulcer: when, why and what to do?. Postgrad Med J 1988; 64: 369–73
   PubMed Web of Science ®Google Scholar
• Dobrilla G, De Pretis G, Amplatz S, Benvenuti S, De Guelmi A. Endogenous and exogenous factors influencing ulcer relapse, resistance to treatment and complications. Gastroenterol Int 1994; 7: 156–71
   Google Scholar
• Reynods J C, Schoen R E, Maislin G, Zangari G G. Risk factors for delayed healing of duodenal ulcers treated with famotidine and ranitidine. Am J Gastroenterol 1994; 89: 571–9
   PubMed Web of Science ®Google Scholar
• Massarrat S, Muller H G, Schmitz-Moormann P. Risk factors for healing of duodenal ulcer under antacid treatment. Do ulcer patients need individual treatment?. Gut 1988; 29: 291–7
   PubMed Web of Science ®Google Scholar
• Saberi-Firoozi M, Massarrat S, Zare S, Fattahi M, Javan A, Etaati H, et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. Am J Gastroenterol 1995; 90: 1419–23
   PubMed Web of Science ®Google Scholar
• Labenz J, Stolte M, Ruhl G H, Becker T, Tillenburg B, Sollbohmer M, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 9–11
   PubMed Web of Science ®Google Scholar
• Forne M, Vivcr J M, Espinos J C, Coll 1, Tresserra F, Garau J. Impact of colloidal bismuth subcitrate in the eradication rates of Helicobacter pylori infection-associated duodenal ulcer using a short treatment regimen with omeprazole and clarithromycin: a randomized study. Am J Gastroenterol 1995; 90: 718–21
   PubMed Web of Science ®Google Scholar
• Jaup B H, Norrby A. Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am Gastroenterol 1995; 90: 943–5
   PubMed Web of Science ®Google Scholar
• Hosking S W, Ling TKW, Chung SCS, Yung M Y, Cheng A F, Sung J J, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508–10
   PubMed Web of Science ®Google Scholar
• Borody T J, George L L, Brandl S, Andrews P, Ostapowicz N, Hyland L, et al. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86: 1154–7
   PubMed Web of Science ®Google Scholar
• Borody T J, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N. Helicobacter pylori-negative gastric ulcer. Am J Gastroenterol 1992; 87: 1403–6
   PubMed Web of Science ®Google Scholar
• Perrault J, Fleming C R, Dozois RR. Surreptitious use of salicylates: a cause of chronic recurrent gastroduodenal ulcers. Mayo Clin Proc 1988; 63: 337–42
   PubMed Web of Science ®Google Scholar
• Hirschowithz B I, Lanas A. NSAID association with gastrointestinal bleeding and peptic ulcer. Agents Actions 1991; 35: 93–101, Suppl
   PubMedGoogle Scholar
• Lanas A, Sekar M C, Hirschowithz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103: 862–5
   PubMed Web of Science ®Google Scholar
• Collen M, Stanczak V, Ciarleglio C. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). Dig Dis Sci 1989; 34: 233–6
   PubMed Web of Science ®Google Scholar
• Deakin M, Colin-Jones D G, Williams JG. Pharmacological response to cimetidine and healing of duodenal ulceration: effects of high-dose cimetidine and combination of cimetidine with pirenzepine. Aliment Pharmacol Ther 1988; 2: 83–7
   PubMedGoogle Scholar
• Bardhan K D. Refractory duodenal ulcer. Gut 1984; 25: 711–4
   PubMed Web of Science ®Google Scholar
• Bardhan K D. Omeprazole in the management of refractory duodenal ulcer. Scand J Gastroenterol 1989; 24: 63–6, Suppl 166
   Web of Science ®Google Scholar
• Kirkparick P M, Hirschowithz B J. Duodenal ulcer with un-explained marked basal gastric acid hypersecretion. Gastroenterology 1980; 79: 4–10
   PubMed Web of Science ®Google Scholar
• Primrose J N, Axon ATR, Johnston D. High selective vagotomy and duodenal ulcers that fail to respond to H2-receptor antagonists. Br Med J 1988; 296: 1031–5
   PubMedGoogle Scholar
• Strom M, Berstad A, Bodemar G, Walan A. Results of short and long-term cimetidine treatment in patients with juxtapyloric ulcers, with special reference to gastric acid and pepsin secretion. Scand J Gastroenterol 1986; 21: 521–4
   PubMed Web of Science ®Google Scholar
• Gledhill L, Buck M, Hunt RH. Effect of no treatment, cimetidine 1 g\day, cimetidine 2 g\day an cimetidine combined with atropine on nocturnal gastric secretion in cimetidine non-responders. Gut 1984; 25: 1, 1211
   PubMed Web of Science ®Google Scholar
• Yanda R J, Ostrof J M, Ashbaugh C D, Guis M, Goldberg HI. Zollinger-Ellison syndrome in a patient with normal screening gastrin level. Dig Dis Sci 1989; 34: 1929–32
   PubMed Web of Science ®Google Scholar
• Jaus P, Mignon M. Normal serum gastrin concentrations in gastrinoma. Lancet 1995; 346: 1421–2
   Web of Science ®Google Scholar
• Samloff I M, Secrist D M, Passaro E, Jr. A study of the relationship between serum group 1 pepsinogen levels and gastric acid secretion. Gastroenterology 1975; 69: 1196–9
   PubMed Web of Science ®Google Scholar
• Alphin R S, Vokac V A, Gregory R L, Bolton P M, Tawes JW, III. Role in intragastric pressure, pH, and pepsin in gastric ulceration in the rat. Gastroenterology 1977; 73: 495–8
   PubMed Web of Science ®Google Scholar
• Xia H X, Gilvarry J, Beattie S, Hamilton H, Keane C T, Sweeney E C, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995; 90: 1221–5
   PubMed Web of Science ®Google Scholar
• Hirschowithz B I, Mohnen J, Shaw S. High recurrence rate of duodenal ulcer despite Helicobacter pylori eradication in a clinical subset–rapidly recurring peptic ulcer (abstract). Gastroenterology 1994; 106: A94
   PubMedGoogle Scholar